The major limitation of this study is lack of FGF15KO/overexpressing mice to elucidate the molecular mechanisms of FGF15/FGFR4 signaling pathway contributing to NASH progression and HCC development. The gene discussed is FGFR4; the disease is hepatocellular carcinoma.